Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRYPTOPHAN Cause Product use in unapproved indication? 23 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Product use in unapproved indication have been filed in association with TRYPTOPHAN (Tryptophan). This represents 22.8% of all adverse event reports for TRYPTOPHAN.

23
Reports of Product use in unapproved indication with TRYPTOPHAN
22.8%
of all TRYPTOPHAN reports
0
Deaths
7
Hospitalizations

How Dangerous Is Product use in unapproved indication From TRYPTOPHAN?

Of the 23 reports, 7 (30.4%) required hospitalization, and 7 (30.4%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRYPTOPHAN. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does TRYPTOPHAN Cause?

Hypotension (25) Drug hypersensitivity (23) Drug ineffective (21) Migraine (19) Drug intolerance (18) Bronchial hyperreactivity (17) Taste disorder (17) Asthma (16) Influenza like illness (16) Myocardial infarction (16)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which TRYPTOPHAN Alternatives Have Lower Product use in unapproved indication Risk?

TRYPTOPHAN vs TUBERCULIN PURIFIED PROTEIN DERIVATIVE TRYPTOPHAN vs TUCATINIB TRYPTOPHAN vs TUCIDINOSTAT TRYPTOPHAN vs TYKERB TRYPTOPHAN vs TYLENOL

Related Pages

TRYPTOPHAN Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication TRYPTOPHAN Demographics